Recent advances in cardiovascular disease research driven by metabolomics technologies in the context of systems biology
Abstract Traditional risk factors and biomarkers of cardiovascular diseases (CVD) have been mainly discovered through clinical observations.Nevertheless, there is still a Pedal Bin gap in knowledge in more sophisticated CVD risk factor stratification and more reliable treatment outcome prediction, highlighting the need for a more comprehensive unde